Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
Clinical trial NCT01554319 · COMPLETED
Trial details
- NCT number
- NCT01554319
- Sponsor
- Sterna Biologicals GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2012-08-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.